Soleno Therapeutics (SLNO) Net Cash Flow (2016 - 2019)
Historic Net Cash Flow for Soleno Therapeutics (SLNO) over the last 7 years, with Q4 2019 value amounting to -$5.0 million.
- Soleno Therapeutics' Net Cash Flow fell 14013.07% to -$5.0 million in Q4 2019 from the same period last year, while for Dec 2019 it was -$16.8 million, marking a year-over-year decrease of 38243.08%. This contributed to the annual value of -$81.8 million for FY2024, which is 15271.96% down from last year.
- According to the latest figures from Q4 2019, Soleno Therapeutics' Net Cash Flow is -$5.0 million, which was down 14013.07% from -$4.3 million recorded in Q3 2019.
- Soleno Therapeutics' 5-year Net Cash Flow high stood at $12.4 million for Q4 2018, and its period low was -$5.0 million during Q4 2019.
- Over the past 5 years, Soleno Therapeutics' median Net Cash Flow value was -$2.2 million (recorded in 2018), while the average stood at -$122735.7.
- As far as peak fluctuations go, Soleno Therapeutics' Net Cash Flow plummeted by 44699.04% in 2016, and later soared by 68365.1% in 2017.
- Soleno Therapeutics' Net Cash Flow (Quarter) stood at $774813.0 in 2015, then tumbled by 446.99% to -$2.7 million in 2016, then surged by 526.0% to $11.5 million in 2017, then increased by 8.2% to $12.4 million in 2018, then crashed by 140.13% to -$5.0 million in 2019.
- Its Net Cash Flow stands at -$5.0 million for Q4 2019, versus -$4.3 million for Q3 2019 and -$3.9 million for Q2 2019.